Video Interview: QureTech Bio Explains Novel Approach To Antibiotic Development
Executive Summary
Dr. Fritiof Pontén, CEO of QureTech Bio—one of Sweden's youngest biotech companies—talks with Mike Ward, global director of content for Informa Pharma Intelligence's insights portfolio, about QureTech's business foundation, its novel technology for disabling bacteria and how the company's products could be a solution to the global challenge of antibiotic resistance.